DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,695,981 | +3.0% | 26,989 | -0.4% | 0.06% | +5.5% |
| Q2 2023 | $6,501,426 | -4.7% | 27,089 | +0.0% | 0.06% | -8.3% |
| Q1 2023 | $6,824,203 | -5.9% | 27,076 | -0.9% | 0.06% | -10.4% |
| Q4 2022 | $7,254,480 | +148.4% | 27,332 | +141.7% | 0.07% | +15.5% |
| Q3 2022 | $2,921,000 | -8.7% | 11,309 | -10.4% | 0.06% | +13.7% |
| Q2 2022 | $3,201,000 | -12.7% | 12,627 | +1.1% | 0.05% | -3.8% |
| Q1 2022 | $3,665,000 | -11.3% | 12,493 | -0.5% | 0.05% | -10.2% |
| Q4 2021 | $4,132,000 | +13.8% | 12,560 | +5.4% | 0.06% | +1.7% |
| Q3 2021 | $3,630,000 | +25.2% | 11,922 | +10.3% | 0.06% | +23.4% |
| Q2 2021 | $2,900,000 | +48.8% | 10,808 | +24.8% | 0.05% | +23.7% |
| Q1 2021 | $1,949,000 | -15.8% | 8,660 | -16.9% | 0.04% | -17.4% |
| Q4 2020 | $2,316,000 | +280.3% | 10,425 | +268.6% | 0.05% | -8.0% |
| Q3 2020 | $609,000 | +73.0% | 2,828 | +42.3% | 0.05% | +51.5% |
| Q2 2020 | $352,000 | +42.5% | 1,988 | +11.4% | 0.03% | +10.0% |
| Q1 2020 | $247,000 | -6.8% | 1,785 | +4.1% | 0.03% | +11.1% |
| Q4 2019 | $265,000 | -7.7% | 1,715 | -13.6% | 0.03% | -22.9% |
| Q3 2019 | $287,000 | +7.9% | 1,984 | +7.4% | 0.04% | +2.9% |
| Q2 2019 | $266,000 | -7.6% | 1,847 | -34.9% | 0.03% | -69.9% |
| Q2 2016 | $288,000 | – | 2,837 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |